Researchers have several options when it comes to seamless cloning methods. The mechanism for each varies quite a bit, as does the resulting sequence accuracy, which we will discuss below. The benefits to any seamless method include the lack of unwanted nucleotides—or scar sequences—between vector and insert, as well as the ability to clone multiple inserts in a specific order in just one round of cloning. However, these research tools lose some of their power if accuracy and/or efficiency suffer. High-throughput applications are particularly affected by any pain points in this regard, as problems with potential error rates or background levels will be magnified when projects are scaled up to accommodate larger cloning needs.
Several commercially available seamless cloning kits, including Gibson Assembly and NEBuilder, utilize a three-enzyme mix consisting of an exonuclease, polymerase, and ligase (Gibson et al. 2009). The mechanism for In-Fusion Cloning (Irwin et al. 2012) differs from this process in a simple but significant way. Both mechanisms require that inserts are amplified by PCR such that they include homologous overlaps with a linear vector or other adjacent fragments, and both utilize an exonuclease to chew back the DNA of linear fragments to create cohesive sticky ends. At this point, the workflows part ways. With the three-enzyme methods, a polymerase fills in any nucleotide gaps, and a DNA ligase then seals the nicks in the annealed fragments prior to the transformation step. This process runs the risk of introducing sequence errors and mismatches at the cloning junction. In contrast, In-Fusion technology does not use a polymerase nor DNA ligase in the cloning mechanism, thus eliminating the potential for nucleotide errors. Cohesive bonds are formed in vivo, preserving the sequence integrity of the clone. In an effort to understand the repercussions of the differences in these mechanisms, we used commercially available kits for each to perform the demanding task of multiple-insert cloning, specifically looking at sequence accuracy as a measure of success.

